Scientific American Talks The Rise of Cryptocurrency
Jen Schwartz, senior editor and blockchain expert at Scientific American, talks the magazine's latest articles on the rise of Bitcoin and what impact cryptocurrencies may have on our future.
Schwartz digs into how what people currently love about cryptocurrency could be seen as a threat in the future. One of the positives of cryptocurrency is its lack of centralization and regulation. But if entire countries begin to use it as their national currency, everything citizens purchase will be seen by the government.
Schwartz digs into some of the biggest questions around the rise of Bitcoin today - how will it benefit everyday people in the long-term? What happens if the bubble bursts, and what will that do for investor trust in cryptocurrency?
Schwartz gives her advice for people looking to possibly invest in Bitcoin, adding that if you are not concerned with losing money and you're looking to experiment, make the investment. If risk is a big concern for you, investing in crypto right now may not be the right move.
Former Medtronic CEO and author of 'True North' Bill George explains the steps Boeing leadership must take to regain client and consumer trust after 737 Max 9 production was stopped.
Amazon blamed "regulatory hurdles" for calling off its proposed acquisition of robot vacuum maker iRobot. Not even a Roomba could clean up the deal's antitrust scrutiny.
To celebrate Flutter Entertainment's debut on the NYSE, FanDuel CEO Amy Howe shares her thoughts on the company's plans for growth, the future of online sportsbetting, and Super Bowl Sunday.
Investopedia's Caleb Silver shares thoughts on the upcoming Fed meeting, why individual investors are still slightly skeptical, and what he's looking for from mega cap tech earnings.
Season's greetings! Tax season, that is. January 29 is the first day you can file your tax return. We walk you through each step — plus a checklist you can download.
The Q-Collar helps protect athletes from impact-related concussions. Now, the U.S. Army is evaluating if the device could help reduce traumatic brain injury cased by blast weapons.
Co-founder and executive chairman of the board at Vaxxinity Lou Reese shares how the company is working to bring vaccines for chronic illnesses like heart disease and Parkinson’s to market with an eye for accessibility.
Mario Veneroso, Kingsview Asset Management Partner, weighs in on the latest economic data and whether the market is pricing in too many rate cuts for the coming year.
